The Black Market for Investigational GLP-1 Drugs

JAMA Medical News Associate Managing Editor Kate Schweitzer and Lead Senior Staff Writer Rita Rubin discuss "Unapproved GLP-1 Drugs Retatrutide and Zenagamtide Sold Online Are No Bargain." Related Content:

• Unapproved GLP-1 Drugs Retatrutide and Zenagamtide Sold Online Are No Bargain